Research suggests that African potato (Hypoxis) has been explored in the context of immune-compromised populations, particularly those living with HIV, though the available evidence base remains extremely limited. The single identified study is a small pilot trial of 26 participants that examined short-term safety rather than directly measuring immune function outcomes, finding no clinically significant changes in organ function markers when hypoxoside was used alongside antiretroviral therapy. Studies of this type and scale are considered preliminary and cannot establish efficacy for immune support, as they are not designed or powered to detect immunological benefits or harms. The authors themselves acknowledged the need for larger, longer-term research before meaningful conclusions can be drawn about the role of African potato in immune function.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Impact of acute, oral ingestion of hypoxoside from African potato on hepatic ... | Other | 2021 | Neutral | 100 |